Male Hypogonadism

Amin S. Herati, M.D., Swaytha Yalamanchi, M.D.

Male Hypogonadism is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Monkeypox

Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 Pandemic

Moderna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

DEFINITION

Male hypogonadism is a clinical syndrome that results from the failure of the testes to produce physiologic testosterone levels as a result of disruption of one or more levels of the hypothalamic-pituitary-testicular axis[6].
Classified as primary (resulting from testicular disease), secondary (resulting from pituitary and/or hypothalamic disease), or combined primary/secondary.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

DEFINITION

Male hypogonadism is a clinical syndrome that results from the failure of the testes to produce physiologic testosterone levels as a result of disruption of one or more levels of the hypothalamic-pituitary-testicular axis[6].
Classified as primary (resulting from testicular disease), secondary (resulting from pituitary and/or hypothalamic disease), or combined primary/secondary.

There's more to see -- the rest of this topic is available only to subscribers.